Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience
The use of 0.125% atropine eye drops significantly reduced myopia progression, with approximately 50% reduction in AL elongation compared to controls. Given its effectiveness and variable compliance, 0.125% atropine eye drops may serve as a viable alternative to low-dose atropine for myopia control.
Authors
- Hae Jung Paik (ORCID: https://orcid.org/0000-0002-4187-9045)
- Hee Kyung Yang (ORCID: https://orcid.org/0000-0002-1140-6036)
- Samuel Ungsoo Kim
- Jinu Han (ORCID: https://orcid.org/0000-0002-8607-6625)
- Dae Hee Kim (ORCID: https://orcid.org/0000-0002-9048-551X)
- Seung Hyun Kim (ORCID: https://orcid.org/0000-0001-5527-6846)
- Kyung-Ah Park (ORCID: https://orcid.org/0009-0004-0212-5170)
Institutions
- Yonsei University (KR)
- Korea University (KR)
- Severance Hospital (KR)
- Samsung Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- Gachon University Gil Medical Center (KR)
- Kim's Eye Hospital (KR)
- Chung-Ang University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Korean Journal of Ophthalmology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3341/kjo.2025.0039
- Citations
- 1
- Primary Topic
- Circadian rhythm and melatonin
- Type
- article
- Field-Weighted Citation Impact
- 0.91